Aurora Cannabis Inc. (ACB) closed at $5.03 in the latest trading session, marking a -1.37% move from the prior day. This change lagged the S&P 500’s daily gain of 0.88%. At the same time, the Dow added 0.57%, and the tech-heavy Nasdaq gained 1.39%.
Prior to today’s trading, shares of the company had lost 31.27% over the past month. This has lagged the Medical sector’s gain of 3.5% and the S&P 500’s gain of 3.54% in that time.
Wall Street will be looking for positivity from ACB as it approaches its next earnings report date. In that report, analysts expect ACB to post earnings of -$0.24 per share. This would mark a year-over-year decline of 300%. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $47.09 million, down 17.42% from the year-ago period.
ACB’s full-year Zacks Consensus Estimates are calling for earnings of -$0.87 per share and revenue of $233.06 million. These results would represent year-over-year changes of +69.58% and +12.15%, respectively.